Logo image of SLDE

SLIDE INSURANCE HOLDINGS INC (SLDE) Stock Fundamental Analysis

USA - NASDAQ:SLDE - US8313491057 - Common Stock

14.96 USD
-0.1 (-0.66%)
Last: 9/26/2025, 8:00:02 PM
14.96 USD
0 (0%)
After Hours: 9/26/2025, 8:00:02 PM
Fundamental Rating

4

SLDE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 146 industry peers in the Insurance industry. SLDE has a medium profitability rating, but doesn't score so well on its financial health evaluation. SLDE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

SLDE had positive earnings in the past year.
SLDE Yearly Net Income VS EBIT VS OCF VS FCFSLDE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

Looking at the Return On Assets, with a value of 9.07%, SLDE belongs to the top of the industry, outperforming 95.89% of the companies in the same industry.
SLDE has a Return On Equity of 29.40%. This is amongst the best in the industry. SLDE outperforms 97.26% of its industry peers.
SLDE has a better Return On Invested Capital (9.59%) than 94.52% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SLDE is above the industry average of 4.47%.
The last Return On Invested Capital (9.59%) for SLDE is above the 3 year average (7.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.07%
ROE 29.4%
ROIC 9.59%
ROA(3y)7.23%
ROA(5y)N/A
ROE(3y)33.23%
ROE(5y)N/A
ROIC(3y)7.63%
ROIC(5y)N/A
SLDE Yearly ROA, ROE, ROICSLDE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 10 20 30 40

1.3 Margins

SLDE has a Profit Margin of 26.00%. This is amongst the best in the industry. SLDE outperforms 97.26% of its industry peers.
SLDE's Operating Margin of 35.59% is amongst the best of the industry. SLDE outperforms 98.63% of its industry peers.
Industry RankSector Rank
OM 35.59%
PM (TTM) 26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLDE Yearly Profit, Operating, Gross MarginsSLDE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SLDE is still creating some value.
Compared to 1 year ago, SLDE has about the same amount of shares outstanding.
Compared to 1 year ago, SLDE has an improved debt to assets ratio.
SLDE Yearly Shares OutstandingSLDE Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
SLDE Yearly Total Debt VS Total AssetsSLDE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

SLDE has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
SLDE has a Debt to Equity ratio of 0.04. This is amongst the best in the industry. SLDE outperforms 84.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.09
WACC8.79%
SLDE Yearly LT Debt VS Equity VS FCFSLDE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SLDE Yearly Current Assets VS Current LiabilitesSLDE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

SLDE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 130.22%, which is quite impressive.
Looking at the last year, SLDE shows a very strong growth in Revenue. The Revenue has grown by 80.74%.
EPS 1Y (TTM)130.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)80.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

SLDE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.95% yearly.
The Revenue is expected to grow by 15.51% on average over the next years. This is quite good.
EPS Next Y59.31%
EPS Next 2Y26.11%
EPS Next 3Y17.95%
EPS Next 5YN/A
Revenue Next Year32.14%
Revenue Next 2Y19.54%
Revenue Next 3Y15.51%
Revenue Next 5YN/A

3.3 Evolution

SLDE Yearly Revenue VS EstimatesSLDE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
SLDE Yearly EPS VS EstimatesSLDE Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.33, the valuation of SLDE can be described as very cheap.
76.71% of the companies in the same industry are more expensive than SLDE, based on the Price/Earnings ratio.
SLDE is valuated cheaply when we compare the Price/Earnings ratio to 27.32, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 5.84, the valuation of SLDE can be described as very cheap.
Based on the Price/Forward Earnings ratio, SLDE is valued a bit cheaper than 78.08% of the companies in the same industry.
SLDE is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.89, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.33
Fwd PE 5.84
SLDE Price Earnings VS Forward Price EarningsSLDE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

91.10% of the companies in the same industry are more expensive than SLDE, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.75
SLDE Per share dataSLDE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

SLDE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SLDE's earnings are expected to grow with 17.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.12
PEG (5Y)N/A
EPS Next 2Y26.11%
EPS Next 3Y17.95%

More info and screens

0

5. Dividend

5.1 Amount

SLDE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SLIDE INSURANCE HOLDINGS INC

NASDAQ:SLDE (9/26/2025, 8:00:02 PM)

After market: 14.96 0 (0%)

14.96

-0.1 (-0.66%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)N/A N/A
Inst Owners24.38%
Inst Owner ChangeN/A
Ins Owners43.27%
Ins Owner Change29.66%
Market Cap1.88B
Analysts78.18
Price Target21.62 (44.52%)
Short Float %2.52%
Short Ratio2.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.74%
PT rev (3m)N/A
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.33
Fwd PE 5.84
P/S 1.91
P/FCF N/A
P/OCF N/A
P/B 2.16
P/tB 2.18
EV/EBITDA 2.75
EPS(TTM)2.04
EY13.64%
EPS(NY)2.56
Fwd EY17.11%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.82
BVpS6.92
TBVpS6.87
PEG (NY)0.12
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.07%
ROE 29.4%
ROCE 12.9%
ROIC 9.59%
ROICexc 14.66%
ROICexgc 25.13%
OM 35.59%
PM (TTM) 26%
GM N/A
FCFM N/A
ROA(3y)7.23%
ROA(5y)N/A
ROE(3y)33.23%
ROE(5y)N/A
ROIC(3y)7.63%
ROIC(5y)N/A
ROICexc(3y)10.71%
ROICexc(5y)N/A
ROICexgc(3y)20.87%
ROICexgc(5y)N/A
ROCE(3y)10.26%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 0.1
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC8.79%
ROIC/WACC1.09
Cap/Depr(3y)95.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.74%
Cap/Sales(5y)N/A
Profit Quality(3y)482.81%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)130.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y59.31%
EPS Next 2Y26.11%
EPS Next 3Y17.95%
EPS Next 5YN/A
Revenue 1Y (TTM)80.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year32.14%
Revenue Next 2Y19.54%
Revenue Next 3Y15.51%
Revenue Next 5YN/A
EBIT growth 1Y128.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.03%
OCF growth 3YN/A
OCF growth 5YN/A